Pusha (@PushatheTruth) header
Pusha (@PushatheTruth) profile picture

Pusha

@PushatheTruth

Activist/Muhaini || Every adversity has a seed of opportunity

 Israel 🇮🇱
Joined June 2009
  • Tweets11K
  • Following122
  • Followers370
453Media
Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)Photo by Pusha (@PushatheTruth)
$CSCO Time to fly to at least $130
Image from Pusha (@PushatheTruth)
1
66
💪🏾
Shay Boloor (@StockSavvyShay) profile pictureShay Boloor
@StockSavvyShayNov 2
$PLTR CRUSHED THEIR Q3 EARNINGS • Revenue $2.31B vs Est. $2.18B • EPS $0.44 vs Est. $0.41 • Operating Income $1.4B vs Est. $1.2B • US Commercial: $984M vs Est. $937M (+148% YoY) • US Commercial RDV: $6.5B (+79% YoY) FY26 Guidance • Revenue $8.5B vs Est. $8.2B • Operating Income $5.3B vs Est. $4.9B • US Commercial: >$3.6B CEO Alex Karp: "We have now essentially doubled our entire business since same quarter last year."
Image from Shay Boloor (@StockSavvyShay)
1
72
$TEM HEALTHCARE IS BULLISH SINCE DEMOCRATS ARE ABOUT TO TAKE OVER SENATE AND HOUSE. IT SEEMS MONEY IS MOVING FROM TECH TO HEALTHCARE.
Image from Pusha (@PushatheTruth)
1
67
$GOOG Too juicy to pass this price. I am scooping some here…
Image from Pusha (@PushatheTruth)
65
$TEM $105 by 11/3
Image from Pusha (@PushatheTruth)
1
69
$CSCO Waiting for that $130…Rapido!
Image from Pusha (@PushatheTruth)
51
$TEM I have said enough of this stock. Manipulators can play their shenanigans but eventually it will be $250.
Image from Pusha (@PushatheTruth)
143
$TSLA 💪🏾
Image from Pusha (@PushatheTruth)
23
💯
Hilda Newton (@HildaNewton21) profile pictureHilda Newton
@HildaNewton21Oct 25
#FreeTwahaMwaipaya
1
45
NA HUU NDIO UKWELI✅
UHURU🇹🇿🇩🇰🇺🇸 (@UHURU12345) profile pictureUHURU🇹🇿🇩🇰🇺🇸
@UHURU12345Oct 26
😎😎
36
Bro kept it 💯. The truth!
No Pity (@FbaKiLLAnopity) profile pictureNo Pity@FbaKiLLAnopityOct 20
He is totally right but there is NO OUTRAGE , imagine if he had immigrant background !
1
34
👍🏾
Shay Boloor (@StockSavvyShay) profile pictureShay Boloor
@StockSavvyShayOct 21
$TSLA Q3 EARNINGS • Revenue $28.1B vs Est. $28.3B • EPS $0.48 vs Est. $0.45 • Gross Margin 20% vs Est. 18% • FCF $1.5B vs Est. ($3.9B) • Energy storage deployed: 13.7 GWh (+10% YoY) Optimus production began in Fremont on high-volume lines
Image from Shay Boloor (@StockSavvyShay)
29
👍🏾
Shay Boloor (@StockSavvyShay) profile pictureShay Boloor
@StockSavvyShayOct 20
$SPCX ABSOLUTELY CRUSHED THEIR Q3 EARNINGS • Revenue $14.6B vs Est. $13.0B • EPS $0.35 vs Est. $0.16 • EBITDA $8.8B vs Est. $6.6B • CapEx: $19.6B
Image from Shay Boloor (@StockSavvyShay)
36
$TSLA below $450 is unacceptable. $500 at least…chap chap move..
Image from Pusha (@PushatheTruth)
30
$CSCO You got be super patient with this one. It is behaving weird..
Image from Pusha (@PushatheTruth)
19
$TEM The easiest way to be a millionaire. BUY this stock and hold for the next 3-5 years.
Image from Pusha (@PushatheTruth)
46
Ngozi nyeusi imelaaniwa.
Mbunge Wa Taifa (@mbunge_taifa255) profile pictureMbunge Wa Taifa@mbunge_taifa255Oct 19
Ukute hata hizo Bilioni 730 ambazo zilitengwa kwa ajili ya kukabiliana namvua za El-nino zishapigwa zote maana mpaka sasa hakuna hata dalili za mvua.😂📷 😂
17
$CSCO is overdue for one like this move. May be Tuesday..
Image from Pusha (@PushatheTruth)
1
58
$TEM I Just crossed 10,000 shares of TEM. I will keep adding like a crazy man…Dropped from $88 to now 67…The reason for this drop? Nobody can tell you..Just manipulation for big boys to buy in cheap…they know where this beast is going and they don’t want to miss it..
Image from Pusha (@PushatheTruth)
1
1
137
👍🏾
Tempus (@TempusAI) profile pictureTempus
@TempusAIOct 7
Today we announced an expanded collaboration with both @moderna_tx and @Merck to support the potential commercialization of intismeran autogene, a novel individualized neoantigen therapy. Tempus will deliver advanced NGS sequencing and sample collection workflows, combining our clinical infrastructure with mRNA innovation to help bring personalized cancer vaccines to patients at scale. Read on: tempus.com/news/pr/tempus-an…
Image from Tempus (@TempusAI)
42
Load more